On Tuesday, I joined 239 other Democratic members of Congress in submitting an amicus brief to the U.S. Court of Appeals for the Fifth Circuit to support the Biden administration’s appeal of the Northern District’s unprecedented ruling. In part, we noted that “[p]roviders and patients rely on the availability of thousands of FDA-approved drugs to treat or manage a range of medical conditions, including asthma, HIV, infertility, heart disease, diabetes, and more. Emergency relief from the order is necessary to mitigate the imminent harm facing members of the public, many of whom rely on the availability of mifepristone for reproductive care—and many more rely on the integrity of FDA’s drug approval process for continued access to life-improving and life-saving drugs. Congress intended to—and did—vest authority in FDA to evaluate and ensure the safety and efficacy of drugs in the United States.” To read the full brief, click here.
Yesterday, the Fifth Circuit Court of Appeals partially stayed the district court’s order, and today the United States Supreme Court granted a further stay of the order pending further action in our nation’s highest court.
Also this week, I introduced the bipartisan Strengthening Community Care Act of 2023, H.R. 2559, along with Congressman John Joyce, M.D. (PA-13), Congresswoman Lisa Blunt Rochester (DE-AL) and Congresswoman Elise Stefanik (NY-21). If enacted, this legislation would renew federal funding for Community Health Centers and the National Health Service Corps through 2028. Without passing reauthorization legislation, federal funding for Community Health Centers and the National Health Service Corps is set to expire this year.
Community Health Centers play an essential role in providing health care to vulnerable populations in Houston and more than 30 million Americans across our country. It is so important that Congress support Community Health Centers and health care providers with the tools and resources needed to ensure positive health outcomes. I was glad to introduce this bipartisan legislation with Reps. Joyce, Blunt Rochester, and Stefanik to reauthorize funding for Community Health Centers and the National Health Service Corps to ensure access to quality health care.
In addition to these bills, I submitted testimony about our district’s priorities for the reauthorization of the Federal Aviation Administration. This bill is passed every five years, so I worked with local stakeholders–including the Sugar Land Regional Airport–to develop my top priorities for this year's bill and to convey those to the House Transportation & Infrastructure Committee. Also this week, I led a letter to Federal Transit Administrator Nuria Fernandez supporting Houston METRO's application for the Low or No-Emission Grant. The Low or No Emission program provides federal funding to state and local governments to purchase or lease zero-emission and low-emission transit buses, and I am glad to support Houston METRO in this effort.
I joined my Texas colleagues in sending a letter to House Appropriations Committee leaders addressing Texas residents’ disadvantage when it comes to obtaining Low Income Home Energy Assistance Program (LIHEAP) funding. The letter requests that more Fiscal Year 2024 funds be allocated to the program’s new formula, which shifts funding to warmer-weather states and, in turn, increases the amount of funding available to Texas residents.